ALPMY

Astellas Pharma Inc

ALPMY·04623U102·US·ADR·Healthcare - Drug Manufacturers - General

ALPMY (Astellas Pharma Inc) is held by 3 institutional investors as of Q2 2026. Largest holders: RHUMBLINE ADVISERS ($289,348), First Command Advisory Services, Inc. ($17,087), PNC FINANCIAL SERVICES GROUP, INC. ($936). Net institutional sentiment: Mixed.

3
Holders
(1 Elite)
$307,371
Total Value
67% (3)
Consensus
2 buying - 1 selling
13F: Insider & Congress: Updated regularly
ALPMY

Smart Money Verdict

View all
Loading verdict
Held by 3 funds
1 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for ALPMY.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
21,642(-0.7%)$289,3480.0%+8.26%
0
New
1,278$17,0870.0%+10.02%
25
Increased
70(+25.0%)$9360.0%+22.71%
9
ALPMYALPMYAstellas Pharma Inc

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used